Saltar al contenido
Merck

The metabolism of 2,5-diphenyloxazole (PPO) in human lymphocytes and rat liver microsomes.

Pharmacology & toxicology (1987-09-01)
J T Ahokas, C Davies, N Jacobsen, N T Kärki, A Philippides, A M Treston
RESUMEN

The oxidative metabolism of 2,5-diphenyloxazole (PPO) is associated with 3-methylcholanthrene inducible cytochrome P-450. The major metabolite formed has m/z of 237, corresponding to hydroxylated PPO. All the possible hydroxylated metabolites of PPO were synthesized and characterized, enabling the assignment of a structure for the major metabolite and two minor metabolites. The metabolites are easily extracted and their fluorescence is quantifiable in alkaline medium with a sample fluorescence to blank fluorescence ratio of 400:1. A sensitive HPLC assay of PPO metabolism was also developed. PPO metabolism is readily catalyzed by 3-methylcholanthrene-induced rat liver microsomes and strongly inhibited by alpha-naphthoflavone, but poorly inhibited by metyrapone or SKF 525A, indicating the involvement of cytochrome P-448 or P1-450 in the metabolism of PPO. With human lymphocytes the method has proven to be a good indicator of "aryl hydrocarbon hydroxylase" (AHH) activity, correlating well with AHH assays using benzo(alpha)pyrene (BP) as a substrate. Both the induced BP and PPO metabolism by human lymphocytes is inhibited by alpha-naphthoflavone, but not by metyrapone.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
2,5-Diphenyloxazole, 99%, suitable for scintillation
Sigma-Aldrich
2,5-Diphenyloxazole, suitable for liquid scintillation spectrometry